Trial Profile
A randomized, prospective study to evaluate bimatoprost or travoprost/timolol in patients with primary open-angle glaucoma
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 23 Sep 2015
Price :
$35
*
At a glance
- Drugs Bimatoprost (Primary) ; Travoprost/timolol
- Indications Open-angle glaucoma
- Focus Therapeutic Use
- 23 Sep 2015 New trial record